The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418-Reference-Cited by-同舟云学术

The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418

Published:2019-05-23 Issue:5 Volume:14 Page:e0216423
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ferguson Michael W.,Gerak Chloe A. N.,Chow Christalle C. T.^ORCID,Rastelli Ettore J.,Elmore Kyle E.,Stahl Florian,Hosseini-Farahabadi Sara,Baradaran-Heravi Alireza,Coltart Don M.,Roberge Michel^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Targeting mutant p53 for efficient cancer therapy;VJN Bykov;Nat Rev Cancer,2017

2. Drugging the p53 pathway: understanding the route to clinical efficacy;KK Hoe;Nat Rev Drug Discov,2014

3. Pharmaceutical therapies to recode nonsense mutations in inherited diseases;H-LR Lee;Pharmacol Ther,2012

4. Cancer syndromes and therapy by stop-codon readthrough;R Bordeira-Carriço;Trends in Molecular Medicine,2012

5. Phenotypic suppression and misreading in Saccharomyces cerevisiae;A Singh;Nature,1979

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds;Biochemical Pharmacology;2024-08

2. Genetics of cystogenesis in base-edited human organoids reveal therapeutic strategies for polycystic kidney disease;Cell Stem Cell;2024-04

3. Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process;PLOS Biology;2023-11-09

4. Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome;International Journal of Molecular Sciences;2023-07-19

5. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development;Biomolecules;2023-06-14